Peroxisome proliferator-activated receptor γ ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2

被引:94
作者
Wakino, S [1 ]
Hayashi, K [1 ]
Kanda, T [1 ]
Tatematsu, S [1 ]
Homma, K [1 ]
Yoshioka, K [1 ]
Takamatsu, I [1 ]
Saruta, T [1 ]
机构
[1] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan
关键词
PPAR gamma; Rho; Rho kinase; SHP-2; hypertension; Vav; pioglitazone; troglitazone;
D O I
10.1161/01.RES.0000142313.68389.92
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands have an antihypertensive effect in vivo, the precise mechanism has not been fully elucidated. We examined their effects on Rho/Rho kinase pathway, a key regulator of vascular tone. In cultured rat aortic smooth muscle cells (RASMC), Rho kinase stimulated by angiotensin II was suppressed by the pretreatment with pioglitazone and troglitazone, and these effects were explained by the inhibition of the Rho translocation to the cell membrane. We evaluated the role of Vav, a GTP/GDP exchange factor upregulating Rho kinase activity, and Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2), a protein tyrosine phosphatase that dephosphorylated Vav and subsequently inactivated Rho kinase. Both pioglitazone and troglitazone upregulated SHP-2, particularly in the cytosolic fraction, and the SHP-2-bound Vav, and reduced the phosphorylation of Vav. Furthermore, 4-week treatment with pioglitazone lowered systolic blood pressure in spontaneously hypertensive rats (SHR) and suppressed the Rho/Rho kinase activity in aortic tissues isolated from SHR. Consistently, the expression of SHP-2 was upregulated in vascular tissues from pioglitazone-treated SHR. The phosphorylated Vav was increased in SHR, compared with that in normotensive Wistar-Kyoto rats (WKY), which was mitigated by pioglitazone. Finally, both basal and angiotensin II-stimulated levels of Rho kinase activity were greater in RASMC from SHR than those from WKY, and the enhanced Rho kinase activity was blocked by pioglitazone or troglitazone in both strains. Collectively, PPARgamma ligands inhibit the Rho/Rho kinase pathway through upregulation of cytosolic SHP-2 expression and inactivation of Vav, and may contribute to the hemodynamic, in addition to metabolic, action in hypertensive metabolic syndrome. The full text of this article is available online at http://circres.ahajournals.org.
引用
收藏
页码:E45 / E55
页数:11
相关论文
共 42 条
[1]   Active Rho kinase (ROK-α) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells [J].
Begum, N ;
Sandu, OA ;
Ito, M ;
Lohmann, SM ;
Smolenski, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6214-6222
[2]  
BOKOCH GM, 1994, J BIOL CHEM, V269, P31674
[3]   BLOOD-PRESSURE-LOWERING BY PIOGLITAZONE - EVIDENCE FOR A DIRECT VASCULAR EFFECT [J].
BUCHANAN, TA ;
MEEHAN, WP ;
JENG, YY ;
YANG, D ;
CHAN, TM ;
NADLER, JL ;
SCOTT, S ;
RUDE, RK ;
HSUEH, WA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :354-360
[4]   Peroxisome proliferator-activated receptor γ ligands increase release of nitric oxide from endothelial cells [J].
Calnek, DS ;
Mazzella, L ;
Roser, S ;
Roman, J ;
Hart, CM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (01) :52-57
[5]   Nitric oxide-induced motility in aortic smooth muscle cells - Role of protein tyrosine phosphatase SHP-2 and GTP-binding protein Rho [J].
Chang, YZ ;
Ceacareanu, B ;
Dixit, M ;
Sreejayan, N ;
Hassid, A .
CIRCULATION RESEARCH, 2002, 91 (05) :390-397
[6]   Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product [J].
Crespo, P ;
Schuebel, KE ;
Ostrom, AA ;
Gutkind, JS ;
Bustelo, XR .
NATURE, 1997, 385 (6612) :169-172
[7]   Increased expression of peroxisome proliferator-activated receptor-α and -γ in blood vessels of spontaneously hypertensive rats [J].
Diep, QN ;
Schiffrin, EL .
HYPERTENSION, 2001, 38 (02) :249-254
[8]   Selective activation of PPARγ inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator [J].
Farrow, B ;
O'Connor, KL ;
Hashimoto, K ;
Iwamura, T ;
Evers, BM .
SURGERY, 2003, 134 (02) :206-212
[9]   Shp-2 tyrosine phosphatase: Signaling one cell or many [J].
Feng, GS .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) :47-54
[10]   Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells [J].
Fukata, Y ;
Amano, M ;
Kaibuchi, K .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (01) :32-39